A network meta-analysis of 82 RCTs (12,796 patients) of endovascular treatment for lower extremity arterial disease found the best device varied by lesion and severity; DES lowered 12-month amputation vs DCB in infrapopliteal CLI, but not robustly. Mortality did not differ.
Meta-analysisn = 12,796
Zhou et al. Network meta-analysis of endovascular treatments for lower extremity arterial disease stratified by lesion location and severity